Immunotherapy for glioblastoma: Playing chess, not checkers

Christopher M. Jackson, Michael Lim

Research output: Contribution to journalArticle


Patients with glioblastoma (GBM) exhibit a complex state of immune dysfunction involving multiple mechanisms of local, regional, and systemic immunosuppression and tolerance. These pathways are now being identified and their relative contributions explored. Delineating how these pathways are interrelated is paramount to effectively implementing immunotherapy for GBM.

Original languageEnglish (US)
Pages (from-to)4059-4061
Number of pages3
JournalClinical Cancer Research
Issue number17
StatePublished - Sep 1 2018


ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this